NLS Pharmaceutics (NLS Pharmaceutics) Price-to-Tangible-Book : (As of Jun. 06, 2024)

View and export this data going back to 2021. Start your Free Trial

What is NLS Pharmaceutics Price-to-Tangible-Book?

As of today (2024-06-06), NLS Pharmaceutics's share price is $0.1318. NLS Pharmaceutics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-0.27. Hence, NLS Pharmaceutics's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for NLS Pharmaceutics's Price-to-Tangible-Book or its related term are showing as below:

During the past 7 years, NLS Pharmaceutics's highest Price to Tangible Book Ratio was 33.64. The lowest was 12.77. And the median was 23.21.

NLSP's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.825
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, NLS Pharmaceutics's share price is $0.1318. NLS Pharmaceutics's Book Value per Sharefor the quarter that ended in Dec. 2023 was $-0.27. Hence, NLS Pharmaceutics's P/B Ratio of today is .

NLS Pharmaceutics Price-to-Tangible-Book Historical Data

The historical data trend for NLS Pharmaceutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NLS Pharmaceutics Price-to-Tangible-Book Chart

NLS Pharmaceutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

33.64

12.77

NLS Pharmaceutics Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial								33.64	-	12.77	-	-

Competitive Comparison of NLS Pharmaceutics's Price-to-Tangible-Book

For the Biotechnology subindustry, NLS Pharmaceutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NLS Pharmaceutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NLS Pharmaceutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where NLS Pharmaceutics's Price-to-Tangible-Book falls into.

NLS Pharmaceutics Price-to-Tangible-Book Calculation

NLS Pharmaceutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.1318	/	-0.272
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

NLS Pharmaceutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of NLS Pharmaceutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

NLS Pharmaceutics (NLS Pharmaceutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NLS Pharmaceutics Ltd (NAS:NLSP) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

The Circle 6, Zurich, CHE, 8058

Website

https://www.nlspharma.com

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.